⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL83351 | 1.00 | — | — | |
| SCHEMBL5986241 | 0.74 | — | — | |
| SCHEMBL5986236 | 0.74 | — | — | |
| SCHEMBL20966 | 0.74 | — | — | |
| SCHEMBL82293 | 0.73 | — | — | |
| SCHEMBL82294 | 0.73 | — | — | |
| SCHEMBL769308 | 0.71 | — | — | |
| SCHEMBL2780868 | 0.71 | — | — | |
| SCHEMBL20060 | 0.71 | — | — | |
| SCHEMBL20059 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240197724-A1 | THERAPEUTIC AGENT FOR GAIT DISTURBANCE | NIPPON SHINYAKU CO., LTD. (JP) | 2024-06-20 | — | — | US | disclosed |
| CN-118201905-A | Cationic lipid | 武田药品工业株式会社 | 2024-06-14 | — | — | CN | disclosed |
| CN-117651552-A | Therapeutic or prophylactic agent for covd-19 | 国立大学法人广岛大学 | 2024-03-05 | — | — | CN | disclosed |
| EP-4316489-A1 | THERAPEUTIC AGENT FOR GAIT DISTURBANCE | Nippon Shinyaku Co., Ltd. (JP) | 2024-02-07 | — | — | EP | disclosed |
| US-20240024266-A1 | Therapeutic Agent or Prophylactic Agent for COVID-19 | HIROSHIMA UNIVERSITY (JP) | 2024-01-25 | — | — | US | disclosed |
| CN-117157075-A | Remedies for gait disorder | 日本新药株式会社 | 2023-12-01 | — | — | CN | disclosed |
| EP-4279494-A1 | METHOD FOR DECOMPOSING COMPOUND, AND COMPOUND | National University Corporation Hokkaido University (JP) | 2023-11-22 | — | — | EP | disclosed |
| EP-4248997-A1 | THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR COVID-19 | Hiroshima University (JP) | 2023-09-27 | — | — | EP | disclosed |
| US-20230218761-A1 | METHOD FOR DECOMPOSING COMPOUND AND COMPOUND | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2023-07-13 | — | — | US | disclosed |
| WO-2023127814-A1 | SUBSTITUTED QUINOLINE DERIVATIVE | ASTELLAS PHARMA INC. (JP) | 2023-07-06 | — | — | WO | disclosed |
| EP-1295875-A1 | HETEROCYCLIC COMPOUNDS | Nippon Shinyaku Co., Ltd. (JP) | 2003-03-26 | — | — | EP | disclosed |
| WO-2002051841-A1 | QUINUCLIDINE CARBAMATE DERIVATIVES AND THEIR USE AS M3 ANTAGONISTS | ALMIRALL PRODESFARMA AG (CH) | 2002-07-04 | — | — | WO | disclosed |
| EP-0632036-B1 | Amide derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | SANKYO CO (JP) | 2000-03-01 | — | — | EP | disclosed |
| US-5614550-A | ANTICHOLESTEROL AGENTS OR ARTERIOSCLEROSIS AGENTS FOR HUMANS | SANKYO COMPANY, LIMITED (JP) | 1997-03-25 | — | — | US | disclosed |
| EP-0513580-B1 | Alpha-phenyl-acrylic acid derivatives, process for their preparation and their use as parasiticides and fungicides | BASF AG (DE) | 1996-10-23 | — | — | EP | disclosed |
| US-5534529-A | Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | SANKYO COMPANY, LIMITED (JP) | 1996-07-09 | — | — | US | disclosed |
| US-5416068-A | Alpha-phenylacrylic acid derivatives, their preparation and their use for controlling pests and harmful fungi | BASF AKTIENGESELLSCHAFT (DE) | 1995-05-16 | — | — | US | disclosed |
| EP-0632036-A2 | Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | SANKYO COMPANY LIMITED (JP) | 1995-01-04 | — | — | EP | disclosed |
| US-5298527-A | Insecticides | BASF AKTIENGESELLSCHAFT (DE) | 1994-03-29 | — | — | US | disclosed |
| EP-0513580-A2 | Alpha-phenyl-acrylic acid derivatives, process for their preparation and their use as parasiticides and fungicides | BASF Aktiengesellschaft (DE) | 1992-11-19 | — | — | EP | disclosed |